canAwayTM

canAwayTM is an all natural, safe and effective preventive or treatment against all types of cancer cells. Its active ingredients have been found in laboratory research to be 10,000 times more powerful in killing colon cancer cells than the commonly used chemotherapy drug Adriamycin, without the horrific side effects associated therewith. canAwayTM attacks only cancer cells, leaving healthy cells as they are. Read further for a more detailed description of its active properties and how it adversely affects cancer cells. The therapuetic dosage of canAwayTM is 2-3 grams taken 3 or 4 times daily.

The active compounds and chemicals in canAwayTM: Annonaceous acetogenins. Eight clinical studies have confirmed that Annonaceous acetogenins have significant antitumorous properties and selective toxicity against various types of cancer cells (without harming healthy cells). These acetogenins have demonstrated selective toxicity to tumor cells at dosages as small as 1 ppm.

Annonaceous acetogenins are only found in the Annonaceae plant family and have been documented with antitumorous activities. Studies have determined that acetogenins are superb inhibitors of enzyme processes that are only found in the membranes of cancerous tumor cells, which is why they are toxic to cancer cells but have no toxicity to healthy cells. Purdue University published information that states that several of the Annonaceous acetogenins were " . . . not only are effective in killing tumors that have proven resistant to anti-cancer agents, but also seem to have a special affinity for such resistant cells."

Purdue's research found that cancer cells that survive chemotherapy can develop resistance to the agent used, as well as to other drugs. This is called multi-drug resistance (MDR). Cancer cells develop resistance to chemotherapy drugs by creating an intracellular pump, which is capable of pushing anticancer agents out of the cell before they can kill it. Only about 2% of cancer cells in any given person might develop this pump, but they are the 2% that can eventually grow and expand to create multidrug-resistant tumors.

Acetogenins are capable of shutting down these intracellular pumps, thereby killing multidrug-resistant tumors. Acetogenins preferentially kill MDR cancer cells by blocking the transfer of ATP. A tumor cell needs energy to grow and reproduce, and a great deal more to run its pump and expel attacking agents. By inhibiting energy to the cell, it can no longer run its pump. When acetogenins block ATP to the tumor cell, the cell no longer has enough energy to operate sustaining processes and it dies. Normal cells seldom develop such a pump; therefore, they don't require large amounts of energy and are not adversely affected by ATP inhibitors. 14 different acetogenins tested thus far demonstrate potent ATP-blocking properties (including several found only in canAwayTM). They also reported that 13 of these 14 acetogenins tested were more potent against MDR breast cancer cells than all three of the standard drugs (adriamycin, vincristine, and vinblastine) used as controls.

The Annonaceous acetogenins in canAwayTM include: annocatalin, annohexocin, annomonicin, annomontacin, annomuricatin A & B, annomuricin A thru E, annomutacin, annonacin, annonacinone, annopentocin A thru C, cis-annonacin, cis-corossolone, cohibin A thru D, corepoxylone, coronin, corossolin, corossolone, donhexocin, epomuricenin A & B, gigantetrocin, gigantetrocin A & B, gigantetrocinone, gigantetronenin, goniothalamicin, iso-annonacin, javoricin, montanacin, montecristin, muracin A thru G, muricapentocin, muricatalicin, muricatalin, muri-catenol, muricatetrocin A & B muricatin D, muricatocin A thru C muricin H, muricin I, muricoreacin, murihexocin 3, murihexocin A thru C, murihexol, murisolin, robustocin, rolliniastatin 1 & 2, saba-delin, solamin, uvariamicin I & IV, xylomaticin.

Biological Activities and Clinical Research - Specific acetogenins in canAwayTM have been reported to be selectively toxic in vitro to the following types of tumor cells: lung carcinoma cell lines; human breast solid tumor lines; prostate adenocarcinoma; pancreatic carcinoma cell lines; colon adenocarcinoma cell lines; liver cancer cell lines; human lymphoma cell lines; and multidrug-resistant human breast adenocarcinoma. The main canAwayTM acetogenin, annonacin, is highly toxic to ovarian, cervical, breast, bladder and skin cancer cell lines at very low dosages.

Caution : canAwayTM has cardiodepressant, vasodilator, and hypotensive (lowers blood pressure) actions. Large dosages can cause nausea and vomiting. Avoid combining canAwayTM with ATP-enhancers like CoQ10, since canAway's mechanism is to deplete ATP energy to cancer cells. Combining canAwayTM with other supplements or products that increase or enhance cellular ATP may reduce the therapeutic effect of canAwayTM.

Drug Interactions: None have been reported; however, canAwayTM may potentiate antihypertensive and cardiac depressant drugs. It may potentiate antidepressant drugs and interfere with MAO-inhibitor drugs. See contraindications.

Contraindications - canAwayTM has demonstrated the following properties:
1. uterine stimulant activity in animal studies on rats. canAwayTM should not be used during pregnancy.
2. hypotensive, vasodilator, and cardiodepressant activities in animal studies. canAwayTM is contraindicated for people with low blood pressure. Someone taking antihypertensive drugs should check with their alopathic doctors before taking canAwayTM and monitor their blood pressure, as medications taken may need to be adjusted.
3. significant in vitro antimicrobial properties. Long-term use of canAwayTM may lead to diminishment of friendly bacteria in the digestive tract due to these properties. Supplementing with probiotics and digestive enzymes is advisable if canAwayTM is used for longer than 30 days.
4. emetic properties. If nausea or vomiting occurs, reduce the dosage accordingly.
5. One study reported an increase in dopamine, norepinephrine, and monomine oxidase activity, as well as a inhibition of serotonin release in stress-induced rats. If sedation or sleepiness occurs, reduce the amount used.

canAwayTM is available in both capsule and tincture form. A tincture is superior to a raw herb product because the tincture is already separated and the various essential elements of the plant are more easily ingested into the body. This means that a tincture works faster, but also the body does not have to expend additional energy to break down the herb for digestion of its therapeutic properties. This greater bioavailability means that a tincture remedy is both more efficient and more effective than a typical herbal product.

120 canAwayTM Capsules 650 mg - 45.00 (4.95 S&H if paying by check or money order)

350 canAwayTM Capsules 650 mg - 105.00 (free shipping and handling)

2.2 oz canAwayTM Eye Dropper Bottle 49.95 (4.95 S&H if paying by check or money order)

8 oz canAwayTM Bottle - 110.00 (free shipping and handling)

The statements contained herein have not been evaluated by the U.S. Food and Drug Administration, an agency instituted and authorized under the Planks of the Communist Manifesto. The information contained in this file is intended for education, entertainment and information purposes only. The information herein is not intended to be used to diagnose, prescribe or replace alopathic medical care. The product described herein is not intended to treat, cure, diagnose, mitigate or prevent any disease.